| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3033 |
| Trial ID | NCT05381181 |
| Disease | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19-UCAR-T |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Safety and Efficacy Evaluation of Next-generation CD19-UCART |
| Year | 2022 |
| Country | China |
| Company sponsor | Bioray Laboratories |
| Other ID(s) | 2021-BRL-301 |
| Cohort 1 | |||||||||||||
|
|||||||||||||